Based on the previous and current findings, we propose that hepatic steatosis and inflammation progress simultaneously during NASH development because liver fat accumulation induces LECT2, which drives inflammation. The gene discussed is LECT2; the disease is metabolic dysfunction-associated steatohepatitis.